HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodriguez-Oroz, M C Articles by Obeso, J A Search for Related Content PubMed PubMed Citation Articles by Rodriguez-Oroz, M C Articles by Obeso, J A

Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation

¹ Department of Neurology and Neurosurgery, Neuroscience Center, Clinica Universitaria and Medical School, Universidad de Navarra, Pamplona, Spain
² Service of Neurology and Neurosurgery, Hospiten, Tenerife, Spain

Correspondence to:
Correspondence to:
Dr J A Obeso
Clinica Universitaria, 31008 Pamplona, Spain; jobeso{at}unav.es

Objective: To evaluate the long term (4 years) efficacy of deep brain stimulation (DBS) of the subthalamic nucleus (STN) in advanced Parkinson’s disease.

Methods: We performed a double blind crossover evaluation of the efficacy of DBS of the STN in the "off" medication condition in 10 patients with Parkinson’s disease. Assessments included the Unified Parkinson’s Disease Rating Scale (UPDRS) part III (motor) and two timed tests (arm tapping and walking). Open evaluation of the effect of stimulation in the off and on drug states preoperatively and at 1 and 4 years postoperatively was also conducted. The latter assessment included the UPDRS parts II (activities of daily living) and III (dyskinesia scale and global assessment) as judged by the patient and examiner. The mean amount of levodopa daily dose at base line, 1 year, and 4 years after surgery was compared.

Results: A significant (p<0.04) effect of stimulation was observed in the overall group regarding both the UPDRS motor and the timed tests. Open evaluation also showed a significant benefit of STN DBS with respect to preoperative assessment in both the motor and activities of daily living scales, dyskinesia scale, and in global assessment. Levodopa daily dose was reduced by 48% and 50% at 1 and 4 years, respectively. There was no difference between the 1 and 4 years evaluations in any of the parameters evaluated. Complications due to stimulation were minor.

Conclusions: DBS of the STN provides a significant and persistent anti-parkinsonian effect in advanced Parkinson’s disease 4 years after surgery.

Abbreviations: ADL, activities of daily living; DBS, deep brain stimulation; STN, subthalamic nucleus; UPDRS, Unified Parkinson’s Disease Rating Scale

Keywords: deep brain stimulation; subthalamic nucleus; long term evolution

This article has been cited by other articles:

				F Klostermann, F Ehlen, J Vesper, K Nubel, M Gross, F Marzinzik, G Curio, and T Sappok Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 522 - 529. [Abstract] [Full Text] [PDF]

				S. Papapetropoulos, J. R. Jagid, C. Sengun, C. Singer, and B. V. Gallo Objective monitoring of tremor and bradykinesia during DBS surgery for Parkinson disease Neurology, April 8, 2008; 70(15): 1244 - 1249. [Abstract] [Full Text] [PDF]

				V Fraix, J-L Houeto, C Lagrange, C Le Pen, P Krystkowiak, D Guehl, C Ardouin, M-L Welter, F Maurel, L Defebvre, et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 443 - 449. [Abstract] [Full Text] [PDF]

				D De Gaspari, C Siri, A Landi, R Cilia, A Bonetti, F Natuzzi, L Morgante, C B Mariani, E Sganzerla, G Pezzoli, et al. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 450 - 453. [Abstract] [Full Text] [PDF]

				M. C. Rodriguez-Oroz, J. A. Obeso, A. E. Lang, J.-L. Houeto, P. Pollak, S. Rehncrona, J. Kulisevsky, A. Albanese, J. Volkmann, M. I. Hariz, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up Brain, October 1, 2005; 128(10): 2240 - 2249. [Abstract] [Full Text] [PDF]

				M Capecci, R A Ricciuti, D Burini, V G Bombace, L Provinciali, M Iacoangeli, M Scerrati, and M G Ceravolo Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 769 - 774. [Abstract] [Full Text] [PDF]

				L. Alvarez, R. Macias, G. Lopez, E. Alvarez, N. Pavon, M. C. Rodriguez-Oroz, J. L. Juncos, C. Maragoto, J. Guridi, I. Litvan, et al. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response Brain, March 1, 2005; 128(3): 570 - 583. [Abstract] [Full Text] [PDF]